The Matrikine Tenascin-C Protects Multipotential Stromal Cells/Mesenchymal Stem Cells from Death Cytokines Such as FasL
Multipotential stromal cells/mesenchymal stem cells (MSCs) are attractive candidates for regenerative therapy due to the ability of these cells to differentiate and positively influence neighboring cells. However, on implantation for wound reconstruction, these cells are lost as they are challenged...
Main Authors: | Griffith, Linda G. (Contributor), Rodrigues, Melanie (Author), Nuschke, Austin (Author), Wells, Alan (Author), Yates, Cecelia C. (Author) |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biological Engineering (Contributor) |
Format: | Article |
Language: | English |
Published: |
Mary Ann Liebert,
2013-10-21T13:00:26Z.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Surface Tethered Epidermal Growth Factor Protects Proliferating and Differentiating Multipotential Stromal Cells from FasL-Induced Apoptosis
by: Rodrigues, Melanie, et al.
Published: (2015) -
Growth factor regulation of proliferation and survival of multipotential stromal cells
by: Rodrigues, Melanie, et al.
Published: (2012) -
Multipotent stromal cells/mesenchymal stem cells and fibroblasts combine to minimize skin hypertrophic scarring
by: Cecelia C. Yates, et al.
Published: (2017-09-01) -
Human mesenchymal stem cells/multipotent stromal cells consume accumulated autophagosomes early in differentiation
by: Nuschke, Austin, et al.
Published: (2015) -
Regulation of FasL expression in glioblastoma cells
by: Wang, Yu-Sheng, et al.
Published: (1999)